GLP-1 and Insulin Resistance: Why It Matters for Women

What insulin resistance actually is

Insulin is the hormone that moves glucose out of the blood and into cells for energy. When cells respond less readily to it, the body compensates by making more insulin — a state called insulin resistance. Higher circulating insulin promotes fat storage, makes weight harder to lose, and in women is closely tied to the hormonal picture of PCOS, where it can drive higher androgen levels and irregular cycles³⁴. This is a general explanation of the physiology, not a diagnosis; it is educational only and not medical advice.

Why women feel it differently

Insulin resistance does not sit in isolation — it interacts with the hormonal shifts women live through. In PCOS it is often a central driver rather than a side note³. Across the menopause transition, changing estrogen and shifting body composition can worsen how the body handles insulin, which is part of why midlife weight can feel newly stubborn. The result many women describe is the same: eating and exercise habits that used to work no longer do, because the underlying metabolic set-point has moved.

Where GLP-1 medicines act

GLP-1 receptor agonists were designed around this machinery. They slow gastric emptying, reduce appetite, and improve the body's insulin response — addressing the metabolic driver, not just the calories¹. Tirzepatide adds a second gut-hormone pathway (GIP) alongside GLP-1, which is one reason it draws interest for insulin-resistant weight and produced the largest average reductions in the obesity trials². In plain terms, these medicines help lower the elevated insulin signal that makes weight stick — which is why they can work when willpower-based approaches have not.

What this means for choosing care

If your weight tracks with insulin resistance, the metabolic effect of treatment matters as much as the scale, and so does the oversight around it. A provider that checks the relevant labs and understands your hormones is worth more than the cheapest vial. Our semaglutide vs tirzepatide guide compares the molecules, the PCOS guide covers the diagnosis-specific conversation, and our Luna Fit Score methodology explains how we weight clinical oversight. Any treatment decision belongs with a clinician who can see your full metabolic and hormonal picture.